We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · December 04, 2022

Sacubitril/Valsartan Improves Health-Related Quality of Life in Patients With HFpEF

European Journal of Heart Failure


Additional Info

European Journal of Heart Failure
Health-Related Quality of Life Outcomes in PARAGON-HF
Eur. J. Heart Fail 2022 Nov 17;[EPub Ahead of Print], A Chandra, CA Polanczyk, BL Claggett, M Vaduganathan, M Packer, MP Lefkowitz, JL Rouleau, J Liu, VC Shi, H Schwende, MR Zile, AS Desai, MA Pfeffer, JJV McMurray, SD Solomon, EF Lewis

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading